Belantamab mafodotin with standard care in transplant-ineligible newly diagnosed multiple myeloma: DREAMM-9 phase I study Meeting Abstract


Authors: Khalaf, Z.; Usmani, S. Z.; Mielnik, M.; Garg, M.; Sandhu, I.; Abdallah, A. O.; Koh, Y.; Oriol, A.; Quach, H.; Weisel, K. C.; Alonso, A.; Ocio, E. M.; Janowski, W.; Min, C. K.; Ramasamy, K.; Sánchez, R. G.; Rodríguez-Otero, P.; Brawley, C.; Egger, J. L.; Kaisermann, M. C.; Hus, M.
Abstract Title: Belantamab mafodotin with standard care in transplant-ineligible newly diagnosed multiple myeloma: DREAMM-9 phase I study
Meeting Title: 65th Annual Scientific Meeting of the British Society for Haematology (BSH)
Journal Title: British Journal of Haematology
Volume: 206
Issue: Suppl. 1
Meeting Dates: 2025 Apr 27-29
Meeting Location: Glasgow, Scotland
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2025-04-01
Language: English
ACCESSION: WOS:001517858300119
PROVIDER: wos
DOI: 10.1111/bjh.20117
Notes: Meeting Abstract: PO52 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Saad Zafar Usmani
    343 Usmani